Skip to main content
Premium Trial:

Request an Annual Quote

Invitrogen Licenses Neural Stem Cell Line from Buck Institute

NEW YORK (GenomeWeb News) - Invitrogen said today that it has licensed an engineered neural stem cell line from the Buck Institute for Age Research.
 
Invitrogen said that the stem cell line, BG01 Olig2-GFP, has been engineered to track the Olig2 gene, which controls a protein that maintains a neural stem cell's ability to replicate early in brain development, and then directs it to form a particular type of neural cell.
 
Joydeep Goswami, vice president of primary and stem cell systems at Invitrogen, said that the company plans to offer the cell line to its customers as well as to “further develop products from the line that will serve as valuable tools in neural stem cell research.”
 
Financial terms of the agreement were not provided.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.